ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

DeVita: No Decision Yet On FCRF Award

July 17, 1987

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

CCRAC Members Say Practicing Physicians Do Not Use Cancer Prevention Methods

August 24, 1979

In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection

August 12, 1983

HHS Carcinogen Guidelines Draft

June 6, 1980